Project Details
Projekt Print View

Identification of immunomodulatory microbial metabolites as novel therapeutics for advanced CRC (P12)

Subject Area Gastroenterology
Medical Microbiology and Mycology, Hygiene, Molecular Infection Biology
Cell Biology
Term since 2025
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 540805631
 
The composition of the microbiome has been documented to be very different in mice kept under SPF conditions and animals with microbes from wild mice (so-called wildlings) leading to distinct immune responses and disease outcome. The project hypothesizes that in contrast to SPF-housed mice wildling microbiota will protect from CRC development and aims therefore to systematically compare the impact of such different microbiota on tumor progression and development of metastasis.
DFG Programme CRC/Transregios
 
 

Additional Information

Textvergrößerung und Kontrastanpassung